
Sign up to save your podcasts
Or


Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner.
18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Ulaner et al. Radiology 2022; 305:419–428.
By The Radiological Society of North America4.7
8888 ratings
Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner.
18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Ulaner et al. Radiology 2022; 305:419–428.

21,973 Listeners

32,073 Listeners

30,782 Listeners

43,680 Listeners

3,212 Listeners

2,441 Listeners

56,692 Listeners

9,551 Listeners

28 Listeners

45 Listeners

207 Listeners

13 Listeners

12 Listeners

40 Listeners

1,169 Listeners